Brief: Lineage Cell Therapeutics Posts Q4 Earnings Per Share $0.01
March 11 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL
YEAR
2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* Q4 REVENUE $400,000 VERSUS $1.2 MILLION
* Q4 EARNINGS PER SHARE $0.01
* Q4 REVENUE ESTIMATE $817,000 -- REFINITIV IBES DATA
* Q4 EARNINGS PER SHARE ESTIMATE $-0.05 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nBwbzZqQ8a
Further company coverage: LCTX.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million